Pictet Asset Management Sa Molecular Templates, Inc. Transaction History

Pictet Asset Management Sa

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.33 - $12.0 $357,151 - $13 Million	-1,082,277 Reduced 37.28%	1,820,903 $597,000
Q2 2022 Aug 09, 2022	SELL	$0.81 - $3.43 $247,150 - $1.05 Million	-305,124 Reduced 9.51%	2,903,180 $2.65 Million
Q1 2022 May 13, 2022	SELL	$2.27 - $4.13 $210,463 - $382,912	-92,715 Reduced 2.81%	3,208,304 $11.1 Million
Q4 2021 Feb 10, 2022	SELL	$3.37 - $6.87 $289,661 - $590,497	-85,953 Reduced 2.54%	3,301,019 $12.9 Million
Q3 2021 Nov 12, 2021	BUY	$5.78 - $7.86 $19.6 Million - $26.6 Million	3,386,972 New	3,386,972 $22.7 Million

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet Asset Management Sa with notifications on news.